JENNIFER HELENIAK: Open Payments
NPI 1851669766 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,544 in 138 payments from 20 companies in 2025. Trend: 2023 $1,779 · 2024 $2,199 · 2025 $2,544
Food & beverage: $2,472Education: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $819 |
| Teva Pharmaceuticals USA, Inc. | 20 | $318 |
| Boston Scientific Corporation | 5 | $225 |
| PFIZER INC. | 11 | $202 |
| Neurocrine BioSciences, Inc. | 8 | $153 |
| Lundbeck LLC | 12 | $136 |
| Eisai Inc. | 4 | $128 |
| SCILEX PHARMACEUTICALS INC. | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
Products named: UBRELVY, AUSTEDO XR, QULIPTA, NURTEC ODT, BOTOX, INGREZZA, Intracept RF Probe, VYEPTI.
Industry payments across FL — which companies pay providers there.
